Post-COVID-19 syndrome and fibromyalgia
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination
; : 777-782, 2022.
Article
in English
| Scopus | ID: covidwho-2284940
ABSTRACT
A growing body of evidence is suggesting the possible subacute and long-term effects in patients suffering from COVID-19, affecting multiple organ systems. During acute COVID-19, musculoskeletal pain is reported in one-third of patients and it may be also part of the spectrum of post-COVID-19 syndrome, along with other manifestations. Musculoskeletal pain is the cardinal symptoms of fibromyalgia. In this context, the role of viral infection as a triggering factor for the development of fibromyalgia has been postulated since many years. Thus, the occurrence of post-COVID-19 fibromyalgia may be postulated. Several COVID-19-specific mechanisms may contribute to the pathophysiology of the subsequent musculoskeletal syndrome, such as a small fiber neuropathy, an autonomic dysfunction, and an immunological derangement. Finally, the possible multiple components of the pathogenesis and maintenance of post-COVID-19 fibromyalgia may necessitate a multimodal treatment approach. © 2023 Elsevier Inc. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Topics:
Long Covid
Language:
English
Journal:
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS